Evidence map›Paper›PMID 38551153›Full record

ReviewUrologia2024

Elderly and bladder cancer: The role of radical cystectomy and orthotopic urinary diversion.

Francesco Pio Bizzarri, Eros Scarciglia, Pierluigi Russo, Filippo Marino, Simona Presutti, Seyed Koosha Moosavi, Mauro Ragonese, Marco Campetella, Carlo Gandi, Angelo Totaro and 3 more

Open access · hybridAbstract readReview
In one paragraph

Review in Urologia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Francesco Pio BizzarriDepartment of Urology Fondazione Policlinico "Agostino Gemelli", Università Cattolica del Sacro Cuore, Roma, Italy.ORCID 0000-0003-2119-9023
Eros ScarcigliaDepartment of Urology Fondazione Policlinico "Agostino Gemelli", Università Cattolica del Sacro Cuore, Roma, Italy.
Pierluigi RussoDepartment of Urology Fondazione Policlinico "Agostino Gemelli", Università Cattolica del Sacro Cuore, Roma, Italy.ORCID 0000-0002-7789-9486
Filippo MarinoDepartment of Urology Fondazione Policlinico "Agostino Gemelli", Università Cattolica del Sacro Cuore, Roma, Italy.ORCID 0000-0002-2908-6907
Simona PresuttiDepartment of Urology Fondazione Policlinico "Agostino Gemelli", Università Cattolica del Sacro Cuore, Roma, Italy.
Seyed Koosha MoosaviDepartment of Urology Fondazione Policlinico "Agostino Gemelli", Università Cattolica del Sacro Cuore, Roma, Italy.
Mauro RagoneseDepartment of Urology Fondazione Policlinico "Agostino Gemelli", Università Cattolica del Sacro Cuore, Roma, Italy.ORCID 0000-0002-1919-8729
Marco CampetellaUrology Department, Isola Tiberina-Gemelli Isola Hospital, Catholic University Medical School, Rome, Italy.ORCID 0000-0002-7412-1214
Carlo GandiDepartment of Urology Fondazione Policlinico "Agostino Gemelli", Università Cattolica del Sacro Cuore, Roma, Italy.ORCID 0000-0003-1349-7696
Angelo TotaroDepartment of Urology Fondazione Policlinico "Agostino Gemelli", Università Cattolica del Sacro Cuore, Roma, Italy.
Giuseppe PalermoDepartment of Urology Fondazione Policlinico "Agostino Gemelli", Università Cattolica del Sacro Cuore, Roma, Italy.
Emilio SaccoUrology Department, Isola Tiberina-Gemelli Isola Hospital, Catholic University Medical School, Rome, Italy.ORCID 0000-0003-4640-8354
Marco RacioppiDepartment of Urology Fondazione Policlinico "Agostino Gemelli", Università Cattolica del Sacro Cuore, Roma, Italy.
Università Cattolica del Sacro Cuore · ITAgostino Gemelli University Polyclinic · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of bladder cancer (BC) depends on advancing age and other risk factors, significantly impacting on surgical, functional and oncological outcomes. Radical cystectomy (RC) with urinary diversion is the gold standard therapy for muscle invasive bladder cancer; however, it remains a complex surgery and requires careful analysis of risk factors in order to potentially decrease post-surgical complication rates. Age in surgery is a limiting factor that can modify surgical and oncological outcomes, and is correlated with a high rate of post-dimssion hospital readmissions. The reconstruction of the bladder with the intestine represents a crucial point of radical cystectomy and the urinary derivation (UD) is at the center of many debates. A non-continent UD seems to be the best choice in elderly patients (>75 years old), while orthotopic neobladder (ON) is poorly practiced. We reviewed the literature to identify studies reporting outcomes, complications, patient- selection criteria, and quality-of-life data on elderly patients, who underwent ON following radical cystectomy. Reviewing the literature there is no clear evidence on the use of age as an exclusion criterion. Certainly, the elderly patient with multiple comorbidities is not eligible for ON, preferring other UD or rescue therapies. A careful preoperative selection of elderly patients could greatly improve clinical, surgical and oncological outcomes, giving the chance to selected patients to receive an ON.

Indexed as

CystectomyUrinary Bladder NeoplasmsUrinary DiversionAgedAge FactorsHumansTreatment OutcomeBladder cancerelderly populationmuscle invasive bladder cancerorthotopic neo-bladderurinary diversion

Identifiers

PMID38551153
PMCPMC11308345
OpenAlexW4393309450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.